Published date: 17 March 2022

Last edited date: 2 July 2022

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Approach to market date: 1 December 2024

Contract summary

Industry

  • Albumin - 33141540

Location of contract

England, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£30,000,000

Procurement reference

CM/PHS/22/5652/W

Published date

17 March 2022

Approach to market date

1 December 2024

Contract start date

1 May 2025

Contract end date

31 October 2026

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Human Albumin

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2025/2026 £18,333,333
2026/2027 £11,666,667

About the buyer

Contact name

Jennifer Tierney

Address

Commercial Medicines Unit - NHS England
2nd Floor, Rutland House
Runcorn
WA7 2AS
England

Email

jennifer.tierney@nhs.net